| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.6M | +17.5% | +20.5% |
| R&D Expense | $287K | — | -65.9% |
| SG&A Expense | $12.1M | +1.4% | +5.8% |
| Operating Income | -$1.5M | +46.8% | +47.2% |
| Interest Expense | $814K | +0.1% | +21.3% |
| Pre-tax Income | -$2.3M | +38.0% | +3.1% |
| Income Tax | $60K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.9M | +22.9% | +11.1% |
| Accounts Receivable | $18.0M | +15.0% | +68.5% |
| Inventory | $11.8M | -8.0% | +0.3% |
| Current Assets | $56.4M | +10.0% | +22.2% |
| Total Assets | $85.2M | +5.0% | +33.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.2M | — | — |
| Financing Cash Flow | $10.8M | — | — |
| +0.0% |
| — |
| Net Income | -$2.3M | +39.0% | +3.1% |
| EPS (Basic) | -$0.09 | +43.8% | +25.0% |
| EPS (Diluted) | -$0.09 | +43.8% | +25.0% |
| $39.7M |
| -1.9% |
| +19.1% |
| Long-term Debt | $25.2M | +0.2% | +27.2% |
| Total Liabilities | $59.3M | -4.2% | +11.6% |
| Stockholders' Equity | $25.9M | +34.6% | +137.0% |